StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mylan (MYL) Announces Tentative Approval for "TLD" Under PEPFAR
August 7, 2017 8:07 AM
Mylan N.V. (NASDAQ: MYL), a leading global pharmaceutical company, today announced receipt of tentative approval from the U.S. Food and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Next Articles
Mylan (MYL) PT Lowered to $32 at RBC Capital; Reiterates Sector Perform
August 9, 2017 4:56 PM
Mylan (MYL) PT Lowered to $30 at Cowen Following 2Q Results
August 9, 2017 4:48 PM
Mylan (MYL) Announces Launch of Avonza in India
August 8, 2017 5:56 AM
Mylan Receives Tentative Approval for "TLD" Under PEPFAR
August 7, 2017 8:00 AM